Jiao et al. indicated that serum levels of total BAs were increased in patients with NAFlD, and the percentage of FXR antagonistic DCA was increased, while the percentage of its agonistic CDCA was decreased in NAFlD [33]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.